Tuesday, October 28, 2025
- 10:30AM-12:30PM
-
Abstract Number: 2396
A Machine Learning Algorithm Based on a 15-Autoantibody Profile by a Novel Fully Automated Multiplexed Microarray Immunoassay for the Diagnosis of Autoimmune Connective Tissue Diseases
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2337
A Mediation Analysis of Tofacitinib’s Effects on SF-36: The Roles of Fatigue, Pain, Stiffness, and Mobility in Ankylosing Spondylitis
(2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1869
A miRNA signature consisting of high Let7i-5p, high miR-483-5p, low miR-223- 3p characterizes connective tissue diseases with interstitial lung disease
(1855–1876) Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2204
A Novel Framework for Teratogenicity Counseling for Adolescents and Young Adults (AYAs) with Rheumatic Disease on Teratogenic Medications
(2195–2226) Reproductive Issues in Rheumatic Disorders Posters- 10:30AM-12:30PM
-
Abstract Number: 2155
A Novel TNFAIP3 Mutation Associated with Large Vessel Vasculitis: Expanding the Phenotypic Spectrum of A20 Haploinsufficiency
(2124–2158) Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2011
A Phase 1 placebo controlled, single (SAD) and multiple dose escalation (MAD) safety and pharmacokinetic (PK) study of a novel colchicine analogue ABP-745 in healthy volunteers (HV)
(1990–2014) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2012
A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ABP-671 in Subjects with Hyperuricemia or Gout in China
(1990–2014) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2181
A Pilot High-Fidelity Simulation for Pediatric Rheumatology Learners
(2159–2194) Professional Education Poster- 10:30AM-12:30PM
-
Abstract Number: 2247
A Pilot Study to identify novel autoantibody biomarkers in Rheumatoid Arthritis (RA) patients using Immunome Protein Array
(2227–2264) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2371
A Predictive Model Combining Clinical and Laboratory Parameters to Predict anti-TNF Response in Patients with Psoriatic Arthritis
(2338–2376) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2053
A Prospective Study Unveils Damage Accrual and Myositis Specific Antibodies as Key Risk Factors for Mortality in Myositis
(2052–2078) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 1923
A Real-World Survey On Physicians’ Perspectives Of Uncontrolled Gout And Gout Management Practices.
(1914–1935) Health Services Research Poster III- 10:30AM-12:30PM
-
Abstract Number: 2177
A Rheumatologic Ultrasound (RhUS) Educational Framework: Expert Consensus on RhUS Skills for Adult Rheumatology Fellows in the United States
(2159–2194) Professional Education Poster- 10:30AM-12:30PM
-
Abstract Number: 2542
A Rule Based NLP Pipeline for Glucocorticoid exposure